Scientific press

Published Peer-Reviewed Papers.

B.D. Youl, S.D.T. White, M. Cadogan, D.W. Maizels, I.C. Brooman and A.G. Dalgleish. Goat serum product 'Aimspro' restores conduction in demyelinated human optic nerve fibres. Journal of Clinical Neuroscience. 15th March 2006. (Internet publication only)

R.Mackenzie, M.Kiernan, D.Mackenzie, B.D.Youl. Hyperimmune goat serum for amyotrophic lateral sclerosis. Journal of Clinical Neuroscience 2006;13:1037

Mackenzie R. Follow-up study of hyper-immune goat serum (AIMSPRO®) for amyotrophic lateral sclerosis (letter). Journal of Clinical Neuroscience (accepted for publication)

Published Abstracts.

Burke G, Cavey A, Matthews P, Palace J. The evaluation of a novel 'goat serum' (Aimspro) in Multiple Sclerosis. J Neurology Neurosurgery and Psychiatry 2005;76:1326

Youl BD, White SDT, McIntosh D, Cadogan M, Dalgleish AG, Ginsberg L. Hyperimmune serum reverses conduction block in demyelinated human optic nerve and peripheral nerve fibres (abstract). Joint Sino-British Neurology meeting, Beijing. J Neurology Neurosurgery and Psychiatry 2004;76:615

Moore CEG, Hannan R, McIntosh D. In vivo, human peripheral nerve strength duration time constant changes with Aimspro implicate altered sodium channel function as a putative mechanism of action. Journal of the Neurological Sciences. 2005; Vol 238: Suppl. 1. pS238. (World Congress of Neurology, 2005)

Youl BD, Crum J. Clinical Improvement in Krabbe's Disease case treated with hyperimmune goat serum product Aimspro. Journal of the Neurological Sciences. 2005; Vol 238: Suppl. 1. pS110. (World Congress of Neurology, 2005)

Youl BD, Angus-Leppan H, Hussein N, Brooman I, Fitzsimons RB. Rapid and sustained response to hyperimmune goat serum product in a patient with Myaesthenia Gravis. Journal of the Neurological Sciences. 2005; Vol 238: Suppl. 1. pS177. (World Congress of Neurology, 2005)

Youl BD, Orrell R. Goat serum product Aimspro produces sustained improvement in muscle power in a patient with Fascioscapulohumeral Dystrophy. Journal of the Neurological Sciences. 2005; Vol 238: Suppl. 1. pS169. (World Congress of Neurology, 2005)

Youl BD, White SDT, Cadogan MA, Dalgleish AG (2004). Goat Serum product restores conduction in demyelinated human optic nerve fibres (abstract). J Neurology Neurosurgery and Psychiatry 2005;76:615 (doi: 10.1016/j.clinph.2006.07.239)

Youl BD, Ginsberg L (2004). Goat serum product AIMSPRO shows promise as an effective treatment in CIDP (abstract). BSCN meeting, National Hospital, London, 21st October 2004 - doi: 10.1016/j.clinph.2006.07.249

Moore CEG, Youl BD, Moore WMH, Orrel R (2005). Multimodality neurophysiological testing in the assessment of a novel therapeutic approach to Leukodystrophy and Charcot-Marie-Tooth disease (abstract). BSCN meeting, Sheffield, 18th March 2005 – doi: 10.1016/j.clinph.2006.07.264

Mackenzie R, Kiernan M, McKenzie D, Youl BD (2005). Follow-up study of hyperimmune goat serum in a patient with Amyotrophic Lateral Sclerosis (abstract). 16th International Symposium on ALS/MND, Dublin

Back to News